Patent ID: 11883539
Assignee: SHENZHEN HIGHTIDE BIOPHARMACEUTICAL, LTD.
Field: Pharmaceuticals (Chemistry)
Classification: CPC A | IPC A

Claim 0:
1. A softgel capsule having a unit dose of a pharmaceutical composition, wherein the pharmaceutical composition consists of:
(a) berberine (BBR), or a chloride, sulfate or citrate salt thereof;
(b1) eicosapentaenoic acid (EPA), or an ethyl ester thereof;
(b2) docosahexaenoic acid (DHA), or an ethyl ester thereof; and
(c) a pharmaceutically acceptable excipient, carrier, or diluent,, wherein a weight ratio of the BBR to EPA and DHA is from about 3:1 to about 1:8, and the pharmaceutical composition does not contain any active agent that elicits a biological response, other than said (a), (b1) and (b2).